Ordaos Bio

Private

New York City, New YorkHealthcare & Life Scienceshttps://ordaos.bio/

Last Round

Accelerator

May 31, 2023

Total Funding Raised

$5.3M

Company Overview

Ordaos Bio is a biotechnology company that utilizes a human-enabled, machine-driven drug design platform to create novel mini-proteins for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

generative AIdrug discoveryde novo protein designmini-proteinsbiotech AIin silico drug designprotein engineeringAI drug discoverybiologicstherapeutic candidatesreinforcement learningmeta-learningprecision medicinedrug developmentAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ordaos Bio Comps

Public and private peers based on sector, stage, and business model.

Ordaos Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ordaos Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	May 31, 2023
Seed	Aug 25, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

David Longo

Chief Executive Officer

Executive Team

Ordaos Bio Investors

Notable investors and investment history

Ordaos Bio investors
Investor	Rounds
IAG Capital Partners	Seed
AWS Generative AI Accelerator	Accelerator
Citta Capital	Seed
Route 66 Ventures	Seed
Banyan Pacific Capital	Seed
House Capital	Seed
VTC Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 31, 2023
$300K raised from AWS Generative AI Accelerator.
Aug 25, 2022
$5M round led by VTC Ventures.

View all signals

Ordaos Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ordaos Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ordaos Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York

Employee Range24

Year Founded2019

Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.